QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 发表日期：2016    专题：山东大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Serum miR-221 serves as a biomarker for Parkinson's disease 期刊论文 CELL BIOCHEMISTRY AND FUNCTION, 2016, 卷号: 34, 期号: 7, 页码: 511-515 作者:  Ma, Wenbin;  Li, Yingying;  Wang, Chao;  Xu, Fan;  Wang, Meiling 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/16 biomarker  miR-221  Parkinson's disease  serum miRNA   Association Analysis of Proteasome Subunits and Transporter Associated with Antigen Processing on Chinese Patients with Parkinson's Disease 期刊论文 CHINESE MEDICAL JOURNAL, 2016, 卷号: 129, 期号: 9, 页码: 1053-+ 作者:  Mo, Ming-Shu;  Huang, Wei 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/16 Han Chinese  Proteasome Subunit Beta Type  Sporadie Parkinson's Disease  TAP   Gene expression profiling predicts pathways and genes associated with Parkinson's disease 期刊论文 NEUROLOGICAL SCIENCES, 2016, 卷号: 37, 期号: 1, 页码: 73-79 作者:  Liu, Shuang;  Zhang, Yong;  Bian, Hong;  Li, Xiaohong 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/16 Parkinson's disease  Differentially expressed genes  Pathway enrichment  analysis  Protein-protein interaction network  Hub protein   Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase 期刊论文 JOURNAL OF NEUROINFLAMMATION, 2016, 卷号: 13 作者:  Jiang, Lulu;  Wu, Xuefei;  Wang, Shuo;  Chen, Shih-Heng;  Zhou, Hui 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/16 Neuroinflammation  NADPH oxidase  Clozapine metabolites  Parkinson's  disease  Neuroprotection   Neuroprotective Effects of Tanshinone I Against 6-OHDA-Induced Oxidative Stress in Cellular and Mouse Model of Parkinson's Disease Through Upregulating Nrf2 期刊论文 NEUROCHEMICAL RESEARCH, 2016, 卷号: 41, 期号: 4, 页码: 779-786 作者:  Jing, Xu;  Wei, Xinbing;  Ren, Manru;  Wang, Lingtian;  Zhang, Xiumei 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/16 Tanshinone I  Nrf2  Parkinson's disease  6-OHDA   Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment 期刊论文 INTERNATIONAL JOURNAL OF NANOMEDICINE, 2016, 卷号: 11, 页码: 6547-6559 作者:  Bi, Chenchen;  Wang, Aiping;  Chu, Yongchao;  Liu, Sha;  Mu, Hongjie 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/16 rotigotine  lactoferrin-modified PEG-PLGA nanoparticles  brain  targeting  intranasal delivery  Parkinson's disease   Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease 期刊论文 GENETICS AND MOLECULAR RESEARCH, 2016, 卷号: 15, 期号: 2 作者:  Wang, X.;  Yang, H. A.;  Wang, X. N.;  Du, Y. F. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/16 Parkinson's disease  Substantia nigra  Tyrosine hydroxylase  Cellular  prion protein  Small interfering RNA   Factors associated with Parkinson's disease patients with hyposmia in Chines e han population: a case-control study 期刊论文 BIOMEDICAL RESEARCH-INDIA, 2016, 卷号: 27, 期号: 2, 页码: 513-516 作者:  Wu, Lin;  Liu, Yi-Ming 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/17 Parkinson's disease  Olfactory dysfunction  Non-motor symptoms  Tremor  Constipation   The recommendations of Chinese Parkinson's disease and movement disorder society consensus on therapeutic management of Parkinson's disease 期刊论文 TRANSLATIONAL NEURODEGENERATION, 2016, 卷号: 5 作者:  Chen, Shengdi;  Chan, Piu;  Sun, Shenggang;  Chen, Haibo;  Zhang, Baorong 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/17 Parkinson's disease  Treatment guideline  optimal therapeutic options  China